DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

Zobrazit další vydání (1)

Mutations in DOK7 are a common cause of congenital myasthenia. Treatment with ephedrine or salbutamol is effective, but diagnosis is often delayed. The aim of our study was to find early clues to the diagnosis of DOK7 congenital myasthenic syndrome. We included 23 children of 20 families. Onset of s...

Podrobná bibliografie
Hlavní autoři:	Klein, A, Pitt, M, McHugh, J, Niks, E, Sewry, C, Phadke, R, Feng, L, Manzur, A, Tirupathi, S, DeVile, C, Jayawant, S, Finlayson, S, Palace, J, Muntoni, F, Beeson, D, Robb, SA
Médium:	Journal article
Jazyk:	English
Vydáno:	2013

Podobné jednotky

DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
Autor: Klein, A, a další
Vydáno: (2013)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
Autor: Burke, G, a další
Vydáno: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Autor: Lashley, D, a další
Vydáno: (2010)

Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
Autor: Jephson, C, a další
Vydáno: (2010)

DOK7 congenital myasthenic syndrome.
Autor: Palace, J
Vydáno: (2012)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
Autor: Kinali, M, a další
Vydáno: (2008)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
Autor: Cossins, J, a další
Vydáno: (2012)

Congenital myasthenic syndromes: an update.
Autor: Finlayson, S, a další
Vydáno: (2013)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
Autor: Yamanashi, Y, a další
Vydáno: (2008)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
Autor: Lashley, D, a další
Vydáno: (2009)

Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
Autor: Müller, J, a další
Vydáno: (2007)

DOK7 Mutations in Congenital Myasthenic Syndromes
Autor: J Gordon Millichap
Vydáno: (2007-06-01)

The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
Autor: Beeson, D, a další
Vydáno: (2012)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
Autor: Lashley, D, a další
Vydáno: (2009)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
Autor: Burke, G, a další
Vydáno: (2006)

Clinical features of the DOK7 neuromuscular junction synaptopathy.
Autor: Palace, J, a další
Vydáno: (2007)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
Autor: Finlayson, S, a další
Vydáno: (2016)

Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.
Autor: Beeson, D, a další
Vydáno: (2006)

The congenital myasthenic syndromes.
Autor: Palace, J, a další
Vydáno: (2008)

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
Autor: Cossins, J, a další
Vydáno: (2010)

Congenital myasthenic syndromes.
Autor: Beeson, D, a další
Vydáno: (1997)

DOK7 congenital myasthenic syndrome: case series and review of literature
Autor: Bentolhoda Ziaadini, a další
Vydáno: (2024-06-01)

FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
Autor: Finlayson, S, a další
Vydáno: (2012)

Congenital myasthenic syndromes and the neuromuscular junction.
Autor: Cruz, P, a další
Vydáno: (2014)

Therapeutic strategies for congenital myasthenic syndromes
Autor: Lee, M, a další
Vydáno: (2018)

Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome
Autor: Clausen, L
Vydáno: (2015)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
Autor: Jorge A. Bevilacqua, a další
Vydáno: (2017-09-01)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
Autor: Healy, E, a další
Vydáno: (2014)

Congenital myasthenic syndrome caused by mutations in DPAGT.
Autor: Klein, A, a další
Vydáno: (2015)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
Autor: Finlayson, S, a další
Vydáno: (2013)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
Autor: Belaya, K, a další
Vydáno: (2012)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
Autor: Rodríguez Cruz, P, a další
Vydáno: (2018)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
Autor: Finlayson, S, a další
Vydáno: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
Autor: Finlayson, S, a další
Vydáno: (2013)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
Autor: Mewasingh, L, a další
Vydáno: (2006)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
Autor: Chaouch, A, a další
Vydáno: (2012)

Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
Autor: Munot, P, a další
Vydáno: (2010)

Therapy of myasthenic syndrome
Autor: Palace, J
Vydáno: (2012)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
Autor: Palace, J
Vydáno: (2010)

Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
Autor: Hamuro, J, a další
Vydáno: (2008)